Experiment 942038

Worktypes

PHARMACOLOGY OF EXTRACT - IN HUMANSPATENT DESCRIBED

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.EFFECTS DESCRIBED ARE FROM A MULTI-COMPONENT RX.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
DIABETIC NEUROPATHY IMPROVEMENT
Administration routeORAL
OrganismOenothera biennis (ONAGRACEAE)
CitationHORROBIN,DF: STEWART,C: CARMICHAEL,H: JAMAL,GA:. (1987). USE OF GAMMA-LINOLENIC ACID AND RELATED COMPOUNDS IN THE TREATMENT OF COMPLICATIONS OF DIABETES MELLITUS.. ()
Amount utilized
Compound isolated
DiseaseDIABETICS WITH NEUROPATHY WERE TREATED WITH EVENING PRIMROSE OIL CONTAINING GAMMA-LINOLENIC ACID; AFTER 3 MONTHS THEY SHOWED HIGHLY SIGNIFICANT IMPROVEMENT IN PERIPHERAL NERVE FUNCTION COMPARED TO PLACEBO-TREATED CONTROLS. DOSE GIVEN 6 TIMES DAILY.
Dose amount0.3 GM
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitPERSON
Dose expressionDOSE
ExtractSEED OIL